Belluscura (FRA:9VQ) Receivables Turnover : 0.14 (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Belluscura Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Belluscura's Revenue for the six months ended in Jun. 2023 was €0.34 Mil. Belluscura's average Accounts Receivable for the six months ended in Jun. 2023 was €2.45 Mil. Hence, Belluscura's Receivables Turnover for the six months ended in Jun. 2023 was 0.14.

Belluscura Receivables Turnover Historical Data

The historical data trend for Belluscura's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Receivables Turnover Chart

Belluscura Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Receivables Turnover

7.71

7.03

1.87

1.82

Belluscura Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Receivables Turnover	Get a 7-Day Free Trial				-	1.15	0.28	0.33	0.14

Competitive Comparison of Belluscura's Receivables Turnover

For the Medical Devices subindustry, Belluscura's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Belluscura's Receivables Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Belluscura's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Belluscura's Receivables Turnover falls into.

Belluscura Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Belluscura's Receivables Turnover for the fiscal year that ended in Dec. 2022 is calculated as

	Receivables Turnover (A: Dec. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2022 )	/ (	(Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )
=	1.32	/ (	(0.199	+	1.252)	/	2 )
=	1.32	/	0.7255
=	1.82

Belluscura's Receivables Turnover for the quarter that ended in Jun. 2023 is calculated as

	Receivables Turnover (Q: Jun. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2023 )	/ (	(Accounts Receivable (Q: Dec. 2022 )	+	Accounts Receivable (Q: Jun. 2023 ))	/	count )
=	0.338	/ (	(1.252	+	3.653)	/	2 )
=	0.338	/	2.4525
=	0.14

Belluscura (FRA:9VQ) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Belluscura Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Belluscura's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

BELL:UK

Address

15 Fetter Lane, Holborn, London, GBR, EC4A 1BW

Website

https://www.belluscura.com

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines